217 related articles for article (PubMed ID: 31915844)
1. The protective effect of inosine against rotenone-induced Parkinson's disease in mice; role of oxido-nitrosative stress, ERK phosphorylation, and A2AR expression.
El-Shamarka MEA; Kozman MR; Messiha BAS
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jun; 393(6):1041-1053. PubMed ID: 31915844
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic effects of antagonizing adenosine A
Motawi TK; Sadik NAH; Hamed MA; Ali SA; Khalil WKB; Ahmed YR
Mol Cell Biochem; 2020 Feb; 465(1-2):89-102. PubMed ID: 31820278
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic neuroprotective effects of inosine in MPTP-induced parkinsonian mice via brain-derived neurotrophic factor upregulation.
Khanal S; Bok E; Kim J; Park GH; Choi DY
Neuropharmacology; 2023 Nov; 238():109652. PubMed ID: 37422180
[TBL] [Abstract][Full Text] [Related]
4. Selective A
Fathalla AM; Soliman AM; Moustafa AA
Neurosci Lett; 2017 Mar; 643():89-96. PubMed ID: 28213070
[TBL] [Abstract][Full Text] [Related]
5. Parkinsonism-like Disease Induced by Rotenone in Rats: Treatment Role of Curcumin, Dopamine Agonist and Adenosine A
Naser AFA; Aziz WM; Ahmed YR; Khalil WKB; Hamed MAA
Curr Aging Sci; 2022 Feb; 15(1):65-76. PubMed ID: 34042043
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A
Nunes ACL; Carmo M; Behrenswerth A; Canas PM; Agostinho P; Cunha RA
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732120
[TBL] [Abstract][Full Text] [Related]
7. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
[TBL] [Abstract][Full Text] [Related]
8. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
[TBL] [Abstract][Full Text] [Related]
9. Nanostructure lipid carriers enhance alpha-mangostin neuroprotective efficacy in mice with rotenone-induced neurodegeneration.
Sakamula R; Yata T; Thong-Asa W
Metab Brain Dis; 2022 Jun; 37(5):1465-1476. PubMed ID: 35353275
[TBL] [Abstract][Full Text] [Related]
10. Inosine attenuates rotenone-induced Parkinson's disease in rats by alleviating the imbalance between autophagy and apoptosis.
El-Latif AMA; Rabie MA; Sayed RH; Fattah MAAE; Kenawy SA
Drug Dev Res; 2023 Sep; 84(6):1159-1174. PubMed ID: 37170799
[TBL] [Abstract][Full Text] [Related]
11. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.
Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M
Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603
[TBL] [Abstract][Full Text] [Related]
12. Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's disease.
Chen Y; Zhang DQ; Liao Z; Wang B; Gong S; Wang C; Zhang MZ; Wang GH; Cai H; Liao FF; Xu JP
Mol Neurodegener; 2015 Mar; 10():4. PubMed ID: 26013581
[TBL] [Abstract][Full Text] [Related]
13. Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.
Kandil EA; Sayed RH; Ahmed LA; Abd El Fattah MA; El-Sayeh BM
Mol Neurobiol; 2018 May; 55(5):4078-4089. PubMed ID: 28585189
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.
Javed H; Azimullah S; Meeran MFN; Ansari SA; Ojha S
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934738
[TBL] [Abstract][Full Text] [Related]
15. Effect of Oleracein E, a Neuroprotective Tetrahydroisoquinoline, on Rotenone-Induced Parkinson's Disease Cell and Animal Models.
Sun H; He X; Liu C; Li L; Zhou R; Jin T; Yue S; Feng D; Gong J; Sun J; Ji J; Xiang L
ACS Chem Neurosci; 2017 Jan; 8(1):155-164. PubMed ID: 27731637
[TBL] [Abstract][Full Text] [Related]
16. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of fingolimod in mouse models of Parkinson's disease.
Zhao P; Yang X; Yang L; Li M; Wood K; Liu Q; Zhu X
FASEB J; 2017 Jan; 31(1):172-179. PubMed ID: 27671228
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective potential of Mentha piperita extract prevents motor dysfunctions in mouse model of Parkinson's disease through anti-oxidant capacities.
Anjum R; Raza C; Faheem M; Ullah A; Chaudhry M
PLoS One; 2024; 19(4):e0302102. PubMed ID: 38625964
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats.
Sharma S; Kumar P; Deshmukh R
Neurochem Int; 2018 Jun; 116():104-111. PubMed ID: 29501454
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective and Therapeutic Effect of Caffeine on the Rat Model of Parkinson's Disease Induced by Rotenone.
Khadrawy YA; Salem AM; El-Shamy KA; Ahmed EK; Fadl NN; Hosny EN
J Diet Suppl; 2017 Sep; 14(5):553-572. PubMed ID: 28301304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
